A 2D-STI echocardiographic diagnostic model established for cardiac amyloidosis complicated with multiple myeloma
Authors:
Open Access
- 17 February 2025
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 426, 133041
Abstract
No abstract availableKeywords
Funding Information
- Suzhou City Science and Technology Bureau
This publication has 38 references indexed in Scilit:
- Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatmentAmerican Journal of Hematology, 2023
- Sex differences in transthyretin cardiac amyloidosisHeart Failure Reviews, 2023
- Echocardiographic and Clinical Predictors of Cardiac Amyloidosis: Limitations of Apical SparingESC Heart Failure, 2021
- Amyloidosis in Heart FailureCurrent Heart Failure Reports, 2019
- Transthyretin Cardiac Amyloidosis: An Update on Diagnosis and TreatmentESC Heart Failure, 2019
- Diagnostic Utility of Cardiac Troponin T Level in Patients with Cardiac AmyloidosisESC Heart Failure, 2017
- Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureAnnals of Hematology, 2010
- Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factorAnnals of Hematology, 2008
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975